<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
<channel>
	<generator>Vivvo CMS 4.1</generator>
	<title>PRI: Public Radio International</title>
	<link>http://www.pri.org/</link>
	<copyright>&amp;copy;2010 Spoonlabs d.o.o.</copyright>
	<image>
		<title>PRI: Public Radio International</title>
		<url>http://www.pri.org/files.php?file=rss_682409203.gif</url>
		<link>http://www.pri.org/</link>
	</image>
	
			
				
					<item>
						
							<title>Patent expires on blockbuster Lipitor drug; generics on the way</title>
							<link>http://www.pri.org/stories/health/patent-expires-on-blockbuster-lipitor-drug-generics-on-the-way-7220.html</link>
							<category>Health and Medicine</category>
							<pubDate>Wed, 30 Nov 2011 11:59:00 -0600</pubDate>
							<description>After 20 years being the only game in town, Pfizer, the manufacturer of Lipitor, is about to get some competition in the space for treating those with chronic high cholesterol. The patent expired Wednesday and one generic drug is ready to hit the market. Others should arrive in six months.</description>
							
						
					</item>
					
							
						
				
			
		




<description>PRI: Public Radio International</description>
</channel>
</rss>